Health
Progress for paralyzed patients: First implanted device is placed to restore arm, hand and finger movement

AI paralyzed man walking
Gert-Jan Oskam, paralyzed for 12 years, is able to walk again thanks to the brain-spine “digital bridge” interface developed at France’s Atomic Energy Commission (CEA). SOURCE: EPFL / CHUV via Reuters
For the first time ever, a human has successfully received an implanted device to enable movement of the arms, hands and fingers after a paralyzing spinal cord injury.
Onward Medical NV, a medical technology company based in the Netherlands, announced on Wednesday the surgical implant of its ARC-IM Stimulator, which is designed to restore function to the upper extremities of paralyzed patients.
The patient, a 46-year-old man, suffered a spinal cord injury nearly two years ago, which left his left side almost fully paralyzed, doctors told Fox News Digital.
WHAT IS ARTIFICIAL INTELLIGENCE?
The ARC-IM implantation took place on Aug. 14 at Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland.
During the procedure, the surgeon, Switzerland-based Dr. Jocelyne Bloch, placed electrodes over the man’s cervical spinal cord.
Switzerland-based neurosurgeon Dr. Jocelyne Bloch performed both surgeries. The procedures went smoothly, she told Fox News Digital. (NeuroRestore)
“There are a total of 32 electrodes that are linked to two different pacemakers,” she told Fox News Digital in an interview. “There are two neurostimulators that are able to produce electricity and give impulses to the spinal cord to activate the muscles of the arm.”
Nine days later, in a follow-up procedure, a wireless brain-computer interface (BCI) was implanted.
“We did a very small craniotomy, which means we removed a bit of bone and replaced it with 64 electrodes,” Bloch said.
PARALYZED MAN REGAINS THIS ‘SIMPLE PLEASURE’ THANKS TO AI ‘DIGITAL BRIDGE’
Working in tandem with the stimulator, the BCI uses artificial intelligence to connect the brain and spinal cord, the company stated in a press release — essentially capturing the intentions of the paralyzed person, “decoding” those thoughts and then stimulating the spinal cord to convert them into actions.

Professor Grégoire Courtine is a co-director of NeuroRestore, a Switzerland-based research, innovation and treatment center that coordinates neurosurgical interventions to restore neurological functions. (NeuroRestore)
The successful surgery has been 20 years in the making, noted Professor Grégoire Courtine, co-director of NeuroRestore, a Switzerland-based research, innovation and treatment center that coordinates neurosurgical interventions to restore neurological functions.
NeuroRestore has worked in partnership with Onward throughout this study.
ARTIFICIAL INTELLIGENCE HELPS DOCTORS PREDICT PATIENTS’ RISK OF DYING, STUDY FINDS: ‘SENSE OF URGENCY’
“When you want to move part of your body, the brain has to send a command to that region to activate the muscles,” Courtine told Fox News Digital in an interview. “When there’s a spinal cord injury, this communication is interrupted. The consequence is paralysis of the limbs.”
With this implant surgery, Courtine said, “We are establishing this communication with a digital bridge that turns thoughts into actions.”

For the first time ever, a human being has received an implanted device to enable movement of the arms, hands and fingers after a paralyzing spinal cord injury. (iStock)
The procedures both went smoothly, the doctors agreed.
Although it’s still too early to provide full results, Bloch said the technology works as expected and appears to “successfully reanimate the patient’s paralyzed arms, hands and fingers.”
“It’s a gradual thing,” she noted. “It’s too early to tell how long it will take — we will be much more knowledgeable in a few months. But it’s not instant — it requires some training.”
AI TECHNOLOGY CATCHES CANCER BEFORE SYMPTOMS WITH EZRA, A FULL-BODY MRI SCANNER
Courtine is optimistic, as he said the devices are “fulfilling expectations” and the stimulation “works very effectively.”
This news comes just a few months after Onward’s May announcement that its ARC-IM and BCI implant had enabled a patient to gain “augmented control” over movement of his paralyzed legs.
“It worked for walking, and so we decided to apply exactly the same technology for hand movement,” Bloch said.

Onward Medical NV, a medical technology company based in the Netherlands, announced on Wednesday the surgical implant of its ARC-IM Stimulator, which is designed to restore function to the upper extremities of paralyzed patients. (Onward Medical)
In the coming months, Onward expects to share more information about the surgery and the results in a peer-reviewed publication.
“At this stage, the technology is very experimental,” Courtine noted.
Years of large-scale clinical trials will need to be completed — and most likely, it won’t be until the end of the decade when this technology is widely available, he said.
“As the unit will possess learning capacity, the patient’s brain will also ‘learn’ to use the device to its fullest capacity.”
Every year, around the world, between 250,000 and 500,000 people suffer a spinal cord injury, according to the World Health Organization (WHO).
Most of these are due to trauma during which a segment of the spinal cord is injured or severed, resulting in neurologic problems at and below the level of the injury, according to Dr. Brett Osborn, a neurosurgeon who practices in Florida. (He was not involved in Onward’s study or the surgery.)

Dr. Brett Osborn is a neurosurgeon and longevity expert who practices in Florida. As Osborn explained, Onward’s technology aims to reestablish the connection between the brain and the nerve roots, bypassing or bridging the level of the spinal cord injury. (Dr. Brett Osborn)
“The spinal cord is mostly a bundle of nerve fibers that descend from the brain like wires,” he said. “If you cut or damage the cables, everything below the injury malfunctions. In a human, this manifests as weakness or paralysis.”
He added, “But what if there was a way to ‘bypass’ the injured region of the spinal cord and directly stimulate the nerve cells that interface with the axons at every spinal level? This is precisely what Onward is attempting to do.”
As Osborn explained, Onward’s technology aims to reestablish the connection between the brain and the nerve roots, bypassing or bridging the level of the spinal cord injury.
MUSICIAN PLAYS SAXOPHONE THROUGH ENTIRETY OF 9-HOUR BRAIN SURGERY
“The wiring is not being repaired — that’s many years in the future. But this is a fancy workaround utilizing state-of-the-art implant technology and AI,” he said.
Echoing Bloch’s and Courtine’s earlier comments, Osborn noted that restoring movement will require a cooperative effort between the patient and the implanted unit.

“There are a total of 32 electrodes that are linked to two different pacemakers,” the surgeon told Fox News Digital during an interview. (Onward Medical)
“As the unit will possess learning capacity, the patient’s brain will also ‘learn’ to use the device to its fullest capacity,” he said. “It will be akin to learning a new skill — to juggle, for example.”
“The brain makes the necessary changes at the cellular level to produce the motor patterns needed to successfully coordinate the rhythmic tossing of the balls, or, in this case, make a muscle.”
“Our nervous system is the most complex object in the universe.”
“AI is our friend here — without which spinal cord-injured patients have little hope,” Osborn added. “After all, our nervous system is the most complex object in the universe.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Dr. Harvey Castro, an emergency medicine physician in Coppell, Texas, is also a consultant and speaker on AI in health care.
“As an ER doctor with two decades of experience in patient care, I find the first in-human implant of ONWARD® Medical’s ARC-IM Stimulator with a Brain-Computer Interface (BCI) to be a significant milestone in spinal cord injury treatment,” he told Fox News Digital.
“However, as with any groundbreaking technology, ethical considerations, pros, cons and unknowns should be scrutinized.”

Harvey Castro, an emergency medicine physician in Coppell, Texas, is also a consultant and speaker on AI in health care. “As with any groundbreaking technology, ethical considerations, pros, cons and unknowns should be scrutinized,” he said of Onward’s tech. (Dr. Harvey Castro)
Among ethical considerations, Castro emphasized the need to clarify the informed consent of potential risks and benefits, data privacy measures and accessibility of the technology.
He also pointed out that many unknown factors remain, specifically in terms of safety concerns, long-term effectiveness and potential interference with other bodily functions or existing medical devices.
“While this technology heralds a promising future for SCI patients, rigorous clinical trials, ethical safeguards and long-term studies are essential for its validation and broader application,” Castro concluded.
For more Health articles, visit www.foxnews.com/health.

Health
Cases of COVID variant BA.2.86 have tripled in 2 weeks, says CDC report

Cases of the COVID-19 variant Omicron BA.2.86, also known as Pirola, have tripled in two weeks, comprising between 5% and 15% of all infections, according to the Centers for Disease Control and Prevention (CDC).
The COVID-19 variant Omicron BA.2.86 — as well as its offshoots, including JN.1 — has been reclassified as a “variant of interest” by the World Health Organization (WHO).
Despite its prevalence, BA.2.86 “does not appear to be driving increases in infections or hospitalizations in the United States,” the CDC stated in its report.
OVER HALF THE PEOPLE WHO GET COVID HAVE LINGERING SYMPTOMS AFTER 3 YEARS, NEW STUDY FINDS
Both the CDC and WHO agree that “the public health risk posed by this variant is low compared with other circulating variants.”
The updated COVID-19 vaccines that were approved by the FDA in September are believed to “increase protection against BA.2.86, as they do for other variants,” the CDC noted.
Cases of the COVID-19 variant Omicron BA.2.86, also known as Pirola, have tripled in two weeks, comprising between 5% and 15% of all infections, according to the CDC. (iStock)
“To date, existing vaccines have been very effective in protecting people, particularly those who have been boosted multiple times through a vaccine or natural infection, not only from symptomatic infection, but importantly from severe disease, hospitalization and death,” said Richard Reithinger, PhD, a distinguished research fellow in the Global Health Division at International Development Group in Washington, D.C., in a statement to Fox News Digital.
COVID IS NOT A CONCERN FOR AMERICANS HEADING INTO CHRISTMAS, OTHER HOLIDAYS, SAYS SURVEY: ‘JUST ANOTHER VIRUS’
The CDC said it is not clear whether BA.2.86 causes different symptoms — but noted that most variants produce similar effects.
“The types of symptoms and how severe they are usually depend more on a person’s immunity than which variant causes the infection,” the statement said.

Despite its prevalence, BA.2.86 (also known as Pirola) “does not appear to be driving increases in infections or hospitalizations in the United States,” the CDC stated in its report. (iStock)
The variant is also expected to respond to the current tests and treatments.
Reithinger noted that while the pandemic is officially over, COVID-19 is not a thing of the past.
“A concern of the new BA.2.86 variant was that because it has 35 mutations in the spike protein, it would be able to evade the immune response more readily than other variants that emerged in the last couple of months,” he told Fox News Digital.
“Early clinical data does not seem to indicate this being the case.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The increase in BA.2.86 cases is due to the U.S. entering the “COVID-19 season” and also a sufficient number of people having developed non-BA.2.86 immunity, according to the doctor.
Outside of vaccines, Reithinger recommends that high-risk groups adopt risk-mitigating behaviors, including wearing masks, frequently washing hands and avoiding crowded environments.

The updated COVID-19 vaccines that were approved by the FDA in September are believed to “increase protection against BA.2.86, as they do for other variants,” the CDC noted. (iStock)
“People — particularly those with greater risk of infection and severe disease — should continue to be sensitized and vigilant about COVID-19 and the disease it may cause,” he told Fox News Digital.
“People who are at greater risk of infection and severe disease should consult with their physicians about whether they should be administered one of the currently available boosters,” he added.
Those at highest risk include people older than 60 years, the immunocompromised, those with comorbidities such as asthma and diabetes, and people working in high-risk-of-exposure employment, such as the service industry, Reithinger noted.
For more Health articles, visit www.foxnews/health.
Health
Friends run for a cure for lupus, completing NYC Marathon in honor of longtime pal and lupus sufferer

All marathoners have their own particular motivations for running a 26.2-mile race — and for Molly Anderson, Sarah Edwards and Laura Haley, it was to honor Rosie De Queljoe Herzog, their longtime friend who is living with lupus.
As a 30th birthday surprise, the three runners flew De Queljoe Herzog from her home in Los Angeles to the Big Apple, where she was able to cheer them on as they ran the New York City Marathon on Nov. 5.
Anderson, Edwards and Haley were part of Team Life Without Lupus, the official competitive team of the Lupus Research Alliance, the largest private funder of lupus research in the world.
FOR AUTOIMMUNE DISEASE SUFFERERS, GINGER MAY ‘PLAY A CRITICAL ROLE’ IN CONTROLLING INFLAMMATION, STUDY FINDS
The four friends shared with Fox News Digital what the experience meant to them — and how its impact is lasting well beyond that one day.
‘Something larger’
It was in 2021 when De Queljoe Herzog, a public relations professional, first started noticing symptoms, including rapid hair loss, joint pain, fatigue, swelling of her face and hands — and a malar rash (butterfly rash) on her face.
Pictured left to right: Molly Supple Anderson, Sarah Edwards, Rosie Herzog and Laura Haley at the NYC Marathon on Nov. 5, 2023. (Lupus Research Alliance)
“In the early days, I attributed the hair loss to a stressful 2020 and stressful work schedule, but it turned out to be something larger,” she told Fox News Digital.
In early 2022, De Queljoe Herzog was officially diagnosed with systemic lupus erythematosus, an inflammatory disease that occurs when the immune system attacks its own tissues.
She was hospitalized due to a lupus flare-up shortly after that.
AUTOIMMUNE DISEASE: A BODY AT WAR WITH ITSELF
“I was put on a number of drugs to help quell the flare,” she said.
“I’ve been able to taper off some of the drugs since then, but am still on a few to help keep future flares at bay. I am no longer in a flare and am back to feeling healthy and ‘normal.’”
Over a decade of friendship
The four friends, all 30 years old, attended college together at the University of Arizona, where they competed on the triathlon team and developed an “inseparable bond,” said De Queljoe Herzog.
Their friendships continued to thrive after graduation. They were in each other’s weddings and took trips together.

Team Life Without Lupus, the official competitive team of the Lupus Research Alliance, are pictured with family and friends. “The energy and spectators, especially all our friends and family who came out to watch, were absolutely electric,” said Edwards. (Lupus Research Alliance)
“We’re all so uniquely different, but have such an incredible time when we’re all together,” De Queljoe Herzog told Fox News Digital.
She was “floored” when her friends said they would be running the NYC Marathon on her behalf to support the Lupus Research Alliance.
RUNNING COULD EASE DEPRESSION AS MUCH AS MEDICATION, STUDY FINDS: ‘EXTEND THE TREATMENT ARSENAL’
“It was such a selfless act of friendship and love,” she told Fox News Digital. “They know how much lupus has impacted my overall health, and to see them rally around me and around lupus research was astonishing.”
De Queljoe Herzog and her husband traveled to New York City to watch the race.
“It was such a fun weekend and race day — we were able to catch them at three different points during the race to cheer them on,” she said. “It was an emotional day that I’ll remember for the rest of my life.”
“They know how much lupus has impacted my overall health, and to see them rally around me and around lupus research was astonishing.”
For those who are just starting their lupus journeys, De Queljoe Herzog stressed the importance of finding a support system to lean on.
“It can be a lonely road, but friends and family make it so much more manageable — especially friends who provide an endless supply of belly laughs.”
A race to remember
For the three runners, the race represented a way to support their friend while also marking a significant accomplishment.
“As much as I would do anything to take Rosie’s symptoms and flares away, I can’t,” said Anderson, who lives in Spain and works as a sports psychologist.

The team is pictured with Rosie De Queljoe Herzog along the race course. “Being able to run with two of my best friends for such a great purpose was incredibly gratifying and emotional,” said Anderson. (Lupus Research Alliance)
“It’s difficult living so far away, but after her diagnosis, I began to brainstorm ways to support her in my own way,” she went on. “That was when I had the idea to fund-raise for lupus research and encourage her to come to support the race.”
The other two runners, Edwards and Haley, were on board right away.
“We have always been motivated by physical and athletic challenges, so this seemed like the perfect combination of a challenge for us and raising money for an amazing cause,” said Edwards, who lives in Bend, Oregon, and works as an outreach coordinator for environmental organizations.
FRIENDS SHORTEN KIDNEY PATIENTS’ LONG WAITS FOR TRANSPLANTS TO MERE MONTHS BY DONATING ORGANS
“I’ve always dreamed of experiencing the magic of New York City and the energy I had always heard about in the marathon setting,” she went on.
Race day exceeded the team’s expectations, the women agreed.
“Being able to run with two of my best friends for such a great purpose was incredibly gratifying and emotional,” said Anderson.

The friends embrace along the NYC Marathon race course. Edwards described the race as “pure magic from start to finish.” (Lupus Research Alliance)
Edwards described the race as “pure magic from start to finish.”
“It was like running on cloud nine — it felt like a dream,” she said. “The energy and spectators, especially all our friends and family who came out to watch, were absolutely electric.”
She added, “My most sore muscles after the race were my cheeks from smiling the whole time.”
“Seeing Rosie at mile 18 made me remember why I was doing this, made me cry and helped me get to the finish line.”
Haley, who lives in Tucson, Arizona, and works as a physical therapist, said the best part of the race was taking the ferry to Staten Island and watching the sunrise over Manhattan with her best friends, as well as running through Brooklyn and the Bronx.
“The people were so fun and full of life, energy and support,” she said.
Haley said she struggled at around mile 16, and found herself wishing she had trained more.

The team is pictured celebrating along the marathon race course. “Every time I got tired or frustrated during training for this race, I would think of how much frustration Rosie has been through with lupus,” Edwards said. (Lupus Research Alliance)
“Oftentimes, while training or running the marathon, I would want to stop or ask myself, ‘Why am I doing this? This is miserable,’” she recalled.
“And those moments are when I would remember Rosie’s challenges. It would make me grateful for my healthy body and carry me through those rough times.”
Haley added, “Seeing Rosie at mile 18 made me remember why I was doing this, made me cry and helped me get to the finish line.”
ARIZONA GRANDMA AND MAN SHE MISTAKENLY TEXTED IN 2016 HOST 8TH THANKSGIVING WITH NEW STRANGER
Running the marathon was “a huge joy” for all of them, said Edwards.
“And what has been even better is raising so much awareness among our family and friends through the fundraising process,” she said. “The more people know about lupus, the more support we can raise to find a cure one day.”
“Every time I got tired or frustrated during training for this race, I would think of how much frustration Rosie has been through with lupus.”
While De Queljoe Herzog is grateful for her friends’ support, they all agree that she is a huge source of motivation for them.
“Before her diagnosis, Rosie was always the most positive person I knew,” said Anderson. “She is an incredible listener and has an incredible ability to process information in a way that is productive. After her diagnosis, she was able to channel these parts of herself to listen to her body and manage her symptoms.”

Lupus is one of the most complex autoimmune diseases, according to the Lupus Research Alliance, which is based in New York City. “It affects each person differently with symptoms that are sometimes hard to detect and differ from patient to patient,” the organization notes on its website. (iStock)
Edwards said thoughts of her friend’s challenges helped get her through the race preparations.
“Every time I got tired or frustrated during training for this race, I would think of how much frustration Rosie has been through with lupus,” she told Fox News Digital.
“She is incredibly thoughtful and the kindest person I know. She motivates me to be a better person every day.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Albert Roy, president and CEO of Lupus Research Alliance, noted the significant impact that all of the teams make toward advancing research.
“We so appreciate how these young women and all the members of our Team Life Without Lupus ran the world’s largest marathon to raise both awareness and funds for lupus research,” he commented to Fox News Digital.
Women make up about 9 out of 10 adults with the disease.
“By pushing themselves to reach the finish line, they challenge us to keep striving to reach our goal — more treatments and ultimately a cure.”
Lupus is one of the most complex autoimmune diseases an individual can have, the organization notes. “It affects each person differently, with symptoms that are sometimes hard to detect and differ from patient to patient,” the group says on its website (lupusresearch.org).
While anyone can get lupus, the disease most often affects women, who make up about 9 out of 10 adults with the disease, the group also notes.
The chronic autoimmune disease affects millions of people worldwide. Doctors don’t know exactly what causes lupus, but they believe that something, or a combination of things, triggers the immune system to attack the body, WebMD indicates.
For more Health articles, visit www.foxnews/health.
Health
Could flu vaccination reduce the risk of heart attacks and cardiovascular deaths?

People who get the flu vaccine may have improved heart health, according to a recent study published in Scientific Reports.
Researchers from the Shahid Beheshti University of Medical Sciences in Tehran, Iran, concluded that patients who received flu vaccinations had a 26% reduced risk of having a heart attack and were 33% less likely to die from cardiovascular disease.
This finding is based on a review of five randomized controlled trials that focused on myocardial disease and influenza vaccines.
CHILDHOOD PNEUMONIA SURGE REPORTED IN NETHERLANDS AMID OUTBREAK IN CHINA
The patients who participated in the studies had all been diagnosed with cardiovascular disease previously and were 61 years old, on average.
Out of the total of 9,059 patients, 4,529 of them received the flu vaccine, while 4,530 received a placebo shot.
People who get the flu vaccine may have improved heart health, according to a recent study published in Scientific Reports. (iStock)
After a nine-month period, 621 of the people who received the placebo shot experienced “major cardiovascular events,” compared to 517 of the patients who received the flu vaccine.
Those outcomes included myocardial infarction, cardiovascular death and stroke.
WHEN MEASURING HEART ATTACK RISK, ONE IMPORTANT RED FLAG IS OFTEN OVERLOOKED, DOCTORS SAY
“Revealing a compelling insight into the potential benefits of influenza vaccination, our comprehensive meta-analysis, based on the latest randomized controlled trial data, demonstrates a significant interaction between influenza vaccination and the reduction of major cardiovascular events,” wrote the researchers of the study.
“Notably, patients who received the influenza vaccine experienced a remarkable risk reduction of over 20% in cardiovascular death.”

Patients who received flu vaccinations had a 26% reduced risk of having a heart attack and were 33% less likely to die from cardiovascular disease. (Joe Raedle/Getty Images)
As for why influenza vaccines seem to reduce the risk, the researchers noted that the shot could prevent inflammation and secondary infections, while also stabilizing plaque amounts in the heart.
The vaccine could also help stimulate the immune system, which the study authors noted is essential for cardiovascular health.
SHOULD YOU GET THE COVID AND FLU VACCINES AT THE SAME TIME?
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and a Fox News medical contributor, called the study “important” and said it “builds on what we already knew.”
He was not involved in the research.

Heart disease is the primary cause of death among U.S. adults, killing one person every 33 seconds, according to the CDC. (iStock)
“It is not surprising that flu shots would decrease the risk of heart attacks,” Siegel told Fox News Digital.
“The flu is one of the great enablers,” he went on. “It adds stress and inflammation to the body and decreases the overall immune response, all of which can lead to acute cardiac events.”
The flu “adds stress and inflammation to the body and decreases the overall immune response.”
The researchers called for further research to “elucidate the precise mechanisms driving this association and to explore the long-term impact of influenza vaccination on cardiovascular outcomes.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
In the meantime, they recommended that “health care providers and policymakers should take heed of these findings and consider prioritizing influenza vaccination for patients with recent cardiovascular disease as a feasible and potentially life-saving preventive measure.”
Fox News Digital reached out to the study authors for additional comment.
Heart disease is the primary cause of death among U.S. adults, killing one person every 33 seconds, according to the Centers for Disease Control and Prevention (CDC).
For more Health articles, visit www.foxnews.com/health.
-
Science1 week ago
Mystery dog disease reaches L.A.; county reports 10 cases of canine respiratory illness
-
Culture1 week ago
Can You Name These Famous Short Stories Based on Their Descriptions?
-
Business7 days ago
Column: OpenAI’s board had safety concerns. Big Tech obliterated them in 48 hours
-
Movie Reviews1 week ago
‘Rustin’ Movie Review: Should You Watch Colman Domingo’s Biopic?
-
Business1 week ago
‘A Beautiful Place That Has a Dragon’: Where Hurricane Risk Meets Booming Growth
-
Business1 week ago
Column: Nonunion automakers are matching the UAW’s great contract, but that may be bad for the UAW
-
Movie Reviews1 week ago
Cricket commentary to movie reviews, this app makes English more accessible – Times of India
-
Business1 week ago
With OpenAI in chaos, the tech recruiting feeding frenzy is on